Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 17 for PANITUMUMAB
  1. Panitumumab is used to treat a type of cancer of the colon or rectum that has spread ... during or after treatment with other chemotherapy drugs. Panitumumab is in a class of medications called monoclonal ...
  2. Drugs Approved for Colon and Rectal Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Fluoroplex (Fluorouracil) Fluorouracil Irinotecan Hydrochloride Leucovorin Calcium Oxaliplatin Panitumumab Regorafenib Stivarga (Regorafenib) Vectibix (Panitumumab) Wellcovorin (Leucovorin Calcium) ...
  3. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Nanoparticle Formulation PAD Palifermin Palonosetron Hydrochloride Pamidronate Disodium Panitumumab Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon ...
  4. How Is Colorectal Cancer Diagnosed? (American Cancer Society)  
    ... anti-cancer drugs such as cetuximab (Erbitux ® ) and panitumumab (Vectibix ® ). MSI testing: Sometimes the tumor tissue will ...
  5. ... colorectal cancer, including bevacizumab (Avastin), cetuximab (Erbitux), and panitumumab (Vectibix). Doctors continue to study the best way ...
  6. Frequently Asked Questions about Pharmacogenomics From the National Institutes of Health (National Human Genome Research Institute)  
    ... shown that the chemotherapy drugs cetuximab (Erbitux) and panitumumab (Vecitibix) do not work very well in the ...
  7. Travelers' Health: Immunocompromised Travelers (Centers for Disease Control and Prevention)  
    ... Betaseron Immunomodulatory; target unknown Natalizumab Tsabri α4-integrin Panitumumab Vectibix EGFR Rilonacept Arcalyst IL-1 Rituximab Rituxan ...
  8. ... that target EGFR, such as cetuximab (Erbitux ® ) and panitumumab (Vectibix ® ), are already used to treat other types ...
  9. Colorectal Cancer From the National Institutes of Health (National Cancer Institute)  
    ... therapy plus chemotherapy. The targeted therapies cetuximab and panitumumab can extend survival or slow tumor growth, respectively, ...
  10. ... for use in head and neck cancers, including panitumumab (Vectibix ® ), lapatinib (Tykerb ® ), and erlotinib (Tarceva ® ). These drugs ...
previous · 1 · 2 · next